Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine in Major Depressive Disorder
NCT01573741Phase 2Unknown
- Start
- Feb 2012
- Primary completion
- Dec 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ketamine in major depressive disorder (MDD), bipolar disorder (BD). Status: unknown.
02
Drugs
ketamine
03
Conditions
major depressive disorder (MDD)bipolar disorder (BD)
Beyond the preview
Go deeper on NCT01573741.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01573741.